Understanding why immunotherapy can affect the heart and how to protect it
Official title: Unraveling the Molecular Mechanisms of Immunotherapy-Associated Myocarditis
Funded at University of Tx Md Anderson Can Ctr · NIH-11364611 · Data updated 2026-11-12
Researchers are studying why certain cancer immunotherapies cause dangerous heart inflammation and how to prevent it, with a focus on patients who receive immune-boosting treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | June 2, 2026 |
| Project end | May 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $706,739 |
| NIH project number | 1R01CA305864-01A1 |
| Project ID | NIH-11364611 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients undergoing immune checkpoint inhibitor therapy could potentially benefit from future strategies arising from this research.
✕Less likely to help
This basic-science work may not directly benefit patients in the short term but aims to improve safety for patients receiving ICIs.
What this research studies
This project uses mouse models to mimic how immune checkpoint inhibitors can trigger myocarditis and arrhythmias in cancer patients. It explores why the heart’s own protective factors, like MANF, are reduced during treatment and how that contributes to harmful immune activity. By uncovering pathways that control heart immune responses, the study aims to identify new targets to keep the heart safe during cancer therapy. The findings could lead to strategies that allow more effective cancer treatment with fewer heart-related side effects.
Why it matters
Potential benefit: If successful, the work could inform new approaches to prevent or mitigate ICI-related heart damage in patients undergoing cancer immunotherapy.
How similar studies have gone: Previous studies in models have shown immune-related heart inflammation can be mitigated by protecting cardiac factors, supporting a path toward new interventions.
Where this research is happening
-
University of Tx Md Anderson Can Ctr
Houston, United States Active
Researchers
- Principal investigator: Lin, Chunru — University of Tx Md Anderson Can Ctr
- Study coordinator: Lin, Chunru
Related research
Other NIH-funded projects on the same topics.
-
Targeted CXCR3 blockade to treat immunotherapy-related heart inflammation
A targeted drug approach aims to prevent or lessen heart inflammation caused by immune therapies in cancer patients, using CXCR3-blocking strategies.
-
Why some cancer immunotherapy drugs cause dangerous heart inflammation
Seeing if blocking a chemical signal that draws T cells into the heart can prevent dangerous heart inflammation in people receiving immune checkpoint inhibitor cancer drugs.
-
Understanding how certain immune cells contribute to heart inflammation caused by cancer treatments.
This study is looking at how certain immune cells can cause heart inflammation in people receiving cancer treatment, with the goal of finding ways to keep patients safer during their therapy.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
A center focused on immunotherapy for pediatric cancers.
This study is exploring new ways to use the body's immune system to fight childhood cancers, aiming to create better treatments for kids whose cancers haven't responded well to standard therapies.
-
Algorithms to find HLA-E neoantigens for cancer immunotherapy
Aims to develop computer methods to discover tumor-specific targets presented by HLA-E to guide new T cell therapies for cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.